Karina Nurhadiah - Multi Medika Co Sec
MMIX Stock | 82.00 1.00 1.20% |
Insider
Karina Nurhadiah is Co Sec of Multi Medika Internasional
Phone | 62 21 2967 6078 |
Web | https://www.multimed.co.id |
Similar Executives
Showing other executives | INSIDER Age | ||
Handoko Soetrisno | Bakrieland Development Tbk | 52 | |
Gatot Sanyoto | Pudjiadi Sons Tbk | 61 | |
I Dewi | Bakrieland Development Tbk | N/A | |
Okder Pendrian | Bakrie Brothers Tbk | 50 | |
Sri Dewi | Elang Mahkota Teknologi | N/A | |
Susanto Ah | Bank Pan Indonesia | N/A | |
Arie Putra | Graha Layar Prima | N/A | |
Marlina Gunawan | Bank Pan Indonesia | 60 | |
Arie Farisandi | Sejahteraraya Anugrahjaya Tbk | N/A | |
Surjadie Tjandra | Bank Pan Indonesia | N/A | |
Shashank Swan | Bakrie Brothers Tbk | N/A | |
Arindya Lubis | Graha Layar Prima | 37 | |
Sreecharan V | Petrosea Tbk | N/A | |
Victoria Tahir | Sejahteraraya Anugrahjaya Tbk | 45 | |
Park Jungsin | Graha Layar Prima | 49 | |
Giatrycks Sianipar | Elang Mahkota Teknologi | 48 | |
Saka Nainggolan | Elang Mahkota Teknologi | N/A | |
Bimo Nimpuno | Bakrie Brothers Tbk | N/A | |
Haryanto Ginting | Petrosea Tbk | 49 | |
Aulia | Graha Layar Prima | 47 | |
Harsya Novwan | Bakrieland Development Tbk | 44 |
Management Performance
Return On Equity | 1.81 | |||
Return On Asset | 0.37 |
Multi Medika Interna Leadership Team
Elected by the shareholders, the Multi Medika's board of directors comprises two types of representatives: Multi Medika inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Multi. The board's role is to monitor Multi Medika's management team and ensure that shareholders' interests are well served. Multi Medika's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Multi Medika's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eveline Susanto, CoFounder CFO | ||
Mengky Mangarek, Founder Director | ||
Karina Nurhadiah, Co Sec | ||
Christopher Lee, Chief Officer | ||
Jacky Raharja, Chief Officer |
Multi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Multi Medika a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 1.81 | |||
Return On Asset | 0.37 | |||
Profit Margin | 0.14 % | |||
Operating Margin | 0.18 % | |||
Shares Owned By Insiders | 7.00 % | |||
Price To Sales | 3.41 X | |||
Revenue | 181.84 B | |||
Gross Profit | 67.57 B | |||
EBITDA | 33.57 B | |||
Book Value Per Share | 27.86 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.